mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis-Reference-Cited by-同舟云学术

mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis

Published:2023-11 Issue:6 Volume:10 Page:
ISSN:2332-7812
Container-title:Neurology Neuroimmunology & Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Blanco Yolanda¹,Escudero Domingo¹,Lleixà Cinta¹,Llufriu Sara¹,Egri Natalia¹^ORCID,García Raquel Ruiz¹^ORCID,Alba Mercedes¹,Aguilar Esther¹,Artola Montse¹,Aldea Novo Marta¹,Alvarez Silvia¹,Caballero Eva¹,Cabrera-Maqueda Jose Maria¹,Fonseca Elianet¹,Guasp Mar¹^ORCID,Hernando Ana¹,Martinez-Hernandez Eugenia¹,Olivé-Cirera Gemma¹,Lopez-Contreras Joaquin¹^ORCID,Martín-Aguilar Lorena¹,Martinez-Martinez Laura¹,Rombauts Alexander¹,Rodés Maria¹,Sabater Lidia¹,Sepulveda Maria¹^ORCID,Solana Elisabeth¹,Tejada-Illa Clara¹,Vidal-Fernández Nuria¹,Vilella Anna¹,Fortuny Claudia¹,Armangué Thaís¹^ORCID,Dalmau Josep O.¹,Querol Luis¹^ORCID,Saiz Albert¹

Affiliation:

1. From the Neuroimmunology and Multiple Sclerosis Unit (Y.B., D.E., S.L., R.R.G., M.A., S.A., J.M.C.-M., M.G., A.H., E.M.-H., M.S., T.A., J.D., A.S.), Hospital Clinic de Barcelona, and Universitat de Barcelona; Neurommunology Program, Fundació de Recerca Clinic Barcelona-IDIBAPS (Y.B., S.L., R.R.G., M.A., E.A., M.A., E.C., J.M.C.-M., E.F., M.G., E.M.-H., G.O.-C., M.R., L.S., M.S., E.S., T.A., J.D., A.S.), Barcelona; Neuromuscular Diseases Unit, Neurology Department (C.L., L.M.-A., C.T.-I., N.V.-F., L...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Neurology

Link

https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200163

Reference43 articles.

1. Efficacy and safety of COVID-19 vaccines

2. Risk–benefit analysis of COVID-19 vaccines — a neurological perspective

3. Diverse functional autoantibodies in patients with COVID-19

4. COVID‐19 vaccination hesitancy among people with chronic neurological disorders: A position paper

5. Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case Report: New-onset relapsing-remitting multiple sclerosis with positive Uhthoff phenomenon after second BNT162b2 dose;F1000Research;2024-08-20

2. Neurological manifestations of immune origin after COVID-19 vaccination: retrospective case study;Frontiers in Pharmacology;2024-08-08

3. Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis;Scientific Reports;2024-05-28